Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment (original) (raw)

Advances in Drug Development for Parkinson's Disease: Present Status

Harikrishna reddy

View PDFchevron_right

Neuroprotection trials in Parkinson's disease: Systematic review

Lesly A Pearce

Movement Disorders, 2009

View PDFchevron_right

Medical Management of Parkinsons Disease: Focus on Neuroprotection

Mireya Alcaraz-zubeldia

Current Neuropharmacology, 2011

View PDFchevron_right

Seven Solutions for Neuroprotection in Parkinson's Disease

Richard Wyse

Movement Disorders, 2020

View PDFchevron_right

Neuroprotective Agents for Management of Parkinson’s disease

Leila Kouti

Journal of Pharmaceutical Care, 2013

View PDFchevron_right

Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials

Erwan Bezard

Trends in Pharmacological Sciences, 2004

View PDFchevron_right

Promising drug targets and associated therapeutic interventions in Parkinson's disease

Dr. Vivek K . Chaturvedi

Neural Regeneration Research

View PDFchevron_right

Concerning neuroprotective therapy for Parkinson’s disease

Zbigniew Wszolek

Journal of Neural Transmission. Supplementa

View PDFchevron_right

Neuroprotection in Parkinson’s disease: facts and hopes

László Vecsei

Journal of Neural Transmission, 2019

View PDFchevron_right

Neuroprotection in Parkinson's Disease: a Realistic Goal?

Giuseppe Di Giovanni

CNS neuroscience & therapeutics, 2010

View PDFchevron_right

Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Symptoms

Dr Palanisamy Sivanandy

International Journal of Environmental Research and Public Health, 2021

View PDFchevron_right

Preclinical Development of Novel Bifunctional Compounds for Parkinson's Disease

Chukwunonso Nwabufo

2019

View PDFchevron_right

Neuroprotection in Parkinson's Disease: A Systematic Review of the Preclinical Data

Toine Pieters

The Open Pharmacology Journal, 2012

View PDFchevron_right

Novel therapeutic strategies in Parkinson’s disease

László Vecsei

European Journal of Clinical Pharmacology, 2009

View PDFchevron_right

Novel pharmacological targets for the treatment of Parkinson's disease

Graham Collingridge

Nature Reviews Drug Discovery, 2006

View PDFchevron_right

A comprehensive review on management of Parkinson’s disease, inclusive of drug discovery and pharmacological approaches

Abdel-Nasser El-Shorbagi

journal of applied pharmaceutical science, 2020

View PDFchevron_right

Neuroprotective Treatments in Parkinson’s Disease

Elif Pamuk Çınar

Turkish Journal Of Neurology, 2019

View PDFchevron_right

Milestones in Parkinson's disease therapeutics

Olivier Rascol

Movement Disorders, 2011

View PDFchevron_right

Emerging therapies in the pharmacological treatment of Parkinson's disease

Miri Nussbaum

Drugs, 2002

View PDFchevron_right

Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection

László Vecsei

CNS Neuroscience & Therapeutics, 2010

View PDFchevron_right

Advances in the treatment of Parkinson's disease

Neha Singh

Progress in Neurobiology, 2007

View PDFchevron_right

Neuroprotection in Parkinson’s disease; a commentary

Maria C Carreras, Federico E Micheli

Neurotoxicity Research, 2002

View PDFchevron_right

Therapeutic and Prophylactic Effect of some Agents on Experimental Induced Parkinson Disease Models Review

Sarvananda Letchuman

Article, 2021

View PDFchevron_right

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020

Richard Wyse

Journal of Parkinson's Disease

View PDFchevron_right

Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of Parkinson's disease

D. Burn

European Journal of Neurology, 2012

View PDFchevron_right

Management of Parkinson׳s disease: Current and future pharmacotherapy

Neha Dahiya

European Journal of Pharmacology, 2015

View PDFchevron_right

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics

Karl Broich

Journal of Neural Transmission, 2012

View PDFchevron_right

Drug treatment of Parkinson’s disease

Freek van Muiswinkel

Biochemical Pharmacology, 2000

View PDFchevron_right

Protection against Parkinson’s disease progression: Clinical experience

Peter Lewitt

Neurotherapeutics, 2008

View PDFchevron_right

Current disease modifying approaches to treat Parkinson's disease

Dan Lindholm

Cellular and molecular life sciences : CMLS, 2015

View PDFchevron_right

A study of novel molecules for parkinson‘s disease treatment molecular mechanisms of neurodegenerative complexities and brain protection

N Krishna Chythanya N

IP Indian Journal of Neurosciences, 2020

View PDFchevron_right